Back
ProShares Short 20+ Yr Treasury Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
49
TBF
ProShares Short 20+ Yr Treasury
Last Price:
$24.92
Seasonality Move:
-4.12%
Sell
41
ASND
Ascendis Pharma AS
Last Price:
$162.72
Seasonality Move:
8.98%
Sell
49
ProShares Short 20+ Yr Treasury (TBF)
is a Sell
Is ProShares Short 20+ Yr Treasury a Buy, Sell or Hold?
-
The current ProShares Short 20+ Yr Treasury [TBF] share price is $24.89. The Score for TBF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
TBF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $162.84. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TBF Stock Price Chart
What is ProShares Short 20+ Yr Treasury's stock price today?
-
The ProShares Short 20+ Yr Treasury share price today is $24.89The current trend is moderately bullish and TBF is experiencing slight selling pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $162.84Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
TBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 52.75 | Buy |
| Chaikin Money Flow: | -5840 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.24 - 25.16) | Buy |
| Bollinger Bands (100): | (23.8 - 24.88) | Buy |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.73 | Buy |
| Relative Strength Index (14 RSI): | 53.99 | Buy |
| Chaikin Money Flow: | -424698 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (156.82 - 166.7) | Buy |
| Bollinger Bands (100): | (134.8 - 163.28) | Buy |
TBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.16 | Sell |
| 20-day SMA: | 24.88 | Buy |
| 50-day SMA: | 24.39 | Buy |
| 200-day SMA: | 23.71 | Buy |
| 8-day EMA: | 25.04 | Sell |
| 20-day EMA: | 24.88 | Buy |
| 50-day EMA: | 24.55 | Buy |
| 200-day EMA: | 24.01 | Buy |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 160.58 | Buy |
| 20-day SMA: | 160.53 | Buy |
| 50-day SMA: | 158.13 | Buy |
| 200-day SMA: | 141.02 | Buy |
| 8-day EMA: | 160.86 | Buy |
| 20-day EMA: | 160.21 | Buy |
| 50-day EMA: | 157.29 | Buy |
| 200-day EMA: | 144.39 | Buy |
ProShares Short 20+ Yr Treasury Earnings Growth & TBF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.59 per share, an increase this year of $2.02 per share, and an increase next year of $7.29 per share.
ProShares Short 20+ Yr Treasury Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||